Is Dare Bioscience Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NASDAQ: DARE) stock is to Buy DARE stock.
Out of 1 analyst, 0 (0%) are recommending DARE as a Strong Buy, 1 (100%) are recommending DARE as a Buy, 0 (0%) are recommending DARE as a Hold, 0 (0%) are recommending DARE as a Sell, and 0 (0%) are recommending DARE as a Strong Sell.
What is DARE's forecast return on equity (ROE) for 2023-2026?
(NASDAQ: DARE) forecast ROE is N/A, which is considered weak.
What is DARE's Price Target?
According to 1 Wall Street analyst that have issued a 1 year DARE price target, the average DARE price target is $7.00, with the highest DARE stock price forecast at $7.00 and the lowest DARE stock price forecast at $7.00.
The Wall Street analyst predicted that Dare Bioscience's share price could reach $7.00 by Aug 11, 2024. The average Dare Bioscience stock price prediction forecasts a potential upside of 1,392.54% from the current DARE share price of $0.47.
What is DARE's forecast return on assets (ROA) for 2023-2026?
(NASDAQ: DARE) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of -0.05%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.